Dan Harki
LightNews LightNews
banner
danharki.bsky.social
Dan Harki
@danharki.bsky.social
88 followers 84 following 4 posts
Professor at the University Minnesota. Membership & International Relationships Chair, ACS MEDI. Medicinal Chemistry. Drug Development. Synthesis. Chemical Biology. LA Dodgers Fan.
Posts Replies Media Videos
Pinned
danharki.bsky.social
Dan Harki @danharki.bsky.social · Apr 27
The #HarkiLab at the #MIKIW2025 meeting at the University of Kansas.
danharki.bsky.social
Congratulations to Mackenzie and Laura!

www.pharmacy.umn.edu/news/mackenz...
Mackenzie Wyllie and Laura Hirsch Awarded Doctoral Dissertation Fellowships
This prestigious award is bestowed upon the University's most outstanding PhD candidates for their accomplishments in highly significant and innovative research areas.
www.pharmacy.umn.edu
May 12, 2025 at 4:44 PM
Reposted by Dan Harki
rscmedchem.rsc.org
Take a look at recent work from Jared J. Anderson and @danharki.bsky.social on the identification of a novel allosteric binding site on the catalytic domain of NF-κB inducing kinase (NIK)🔥⬇

pubs.rsc.org/en/content/a...

📍 @umnmedchem.bsky.social
#chemsky🧪
Identification of a novel allosteric binding site on the catalytic domain of NF-κB inducing kinase (NIK)
NF-κB inducing kinase (NIK) is the central regulatory component of noncanonical NF-κB signalling and has been implicated in a variety of cancers and immune disorders. While NIK has been pursued as a…
pubs.rsc.org
May 7, 2025 at 1:04 PM
danharki.bsky.social
The #HarkiLab at the #MIKIW2025 meeting at the University of Kansas.
April 27, 2025 at 4:53 PM
danharki.bsky.social
New work to characterize the ligandability of NIK with an electrophilic fragment. pubs.rsc.org/en/content/a...
Identification of a novel allosteric binding site on the catalytic domain of NF-κB inducing kinase (NIK)
NF-κB inducing kinase (NIK) is the central regulatory component of noncanonical NF-κB signalling and has been implicated in a variety of cancers and immune disorders. While NIK has been pursued as a t...
pubs.rsc.org
April 19, 2025 at 6:22 PM
Reposted by Dan Harki
cenmag.bsky.social
Treating a deadly childhood cancer with a sideways approach: Degrading a critical scaffolding protein may help treat neuroblastoma. cen.acs.org/acs-news/acs... #chemsky🧪 #biosky
Treating a deadly childhood cancer with a sideways approach
Degrading a critical scaffolding protein may help treat neuroblastoma
cen.acs.org
March 27, 2025 at 5:00 PM